BamSEC and AlphaSense Join Forces
Learn More

IPI Legacy Liquidation Co.

Formerly OTC: IMPLQ
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1
from 8-K 67 pages Asset Purchase Agreement by and Between Jn Bidco LLC, as Purchaser, and Impel Pharmaceuticals Inc., as Seller Dated as of December 18, 2023
12/34/56
EX-10.1
from 8-K 9 pages Impel Pharmaceuticals Inc. Management Incentive Plan
12/34/56
EX-10.4
from 8-K 10 pages Impel Pharmaceuticals Inc. __, 2023
12/34/56
EX-10.3
from 8-K 10 pages 4. Bonus Allocation and Payment. (A) Bonus Pool. the Plan Will Operate Through the Establishment of a Bonus Pool, Which Shall Be Equal to 0.85% of the Net Consideration
12/34/56
EX-10.2
from 8-K 24 pages Form of Warrant
12/34/56
EX-10.1
from 10-Q Pdf Courtesy Copy
12/34/56
EX-10.1
from 10-Q 8 pages Impel Pharmaceuticals Inc. May 1, 2023
12/34/56
EX-10
from 10-K 12 pages Limited Waiver Agreement
12/34/56
EX-10.2
from 10-Q 232 pages Revenue Interest Financing Agreement Dated as of March 17, 2022 Between Impel Neuropharma, Inc., the Purchasers From Time to Time Party Hereto, and Oaktree Fund Administration, LLC, as the Administrative Agent
12/34/56
EX-10.9
from 10-K 10 pages Impel Neuropharma, Inc. April 15, 2021
12/34/56
EX-10.8
from S-1/A 9 pages Impel Neuropharma, Inc. April 15, 2021
12/34/56
EX-10.7
from S-1/A 9 pages Impel Neuropharma, Inc. April 15, 2021
12/34/56
EX-10.6
from S-1/A 10 pages Impel Neuropharma, Inc. April 15, 2021
12/34/56
EX-10.5
from S-1/A 14 pages Impel Neuropharma, Inc. 2021 Employee Stock Purchase Plan
12/34/56
EX-10.4
from S-1/A 66 pages Impel Neuropharma, Inc. 2021 Equity Incentive Plan
12/34/56
EX-10.1
from S-1/A 12 pages Indemnity Agreement
12/34/56
EX-10.11
from S-1 16 pages Warrant to Purchase Shares of Stock of Impel Neuropharma, Inc
12/34/56
EX-10.9
from S-1 84 pages Lease by and Between Bmr-201 Elliott Avenue LLC, a Delaware Limited Liability Company and Impel Neuropharma, Inc., a Delaware Corporation
12/34/56
EX-10.3
from S-1 66 pages Impel Neuropharma, Inc. 2018 Equity Incentive Plan as Adopted on November 30, 2018
12/34/56
EX-10.2
from S-1 54 pages Impel Neuropharma, Inc. 2008 Equity Incentive Plan Originally Adopted on September 3, 2008 Amended Effective January 13, 2010 to Increase Plan Pool From 500,000 to 2,216,165 Shares Amended Effective September 6, 2011 to Increase Plan Pool From 2,216,165 to 3,006,001 Shares Amended Effective February 3, 2014 to Increase Plan Pool From 3,006,001 to 3,750,000 Shares Amended Effective December 31, 2014 to Increase Plan Pool From 3,570,000 to 6,090,578 Shares Amended Effective August 28, 2015 to Increase Plan Pool From 6,090,578 to 6,910,737 Shares Amended Effective November 16, 2016 to Increase Plan Pool From 6,910,737 to 13,210,737 Shares Amended Effective November 16, 2016 to Increase Plan Pool From 13,210,737 to 14,003,181 Shares Amended Effective February 13, 2018 to Increase Plan Pool From 14,003,181 to 20,922,181 Shares
12/34/56